SAGE Journals Online
Advertisement
Sign In to gain access to subscriptions and/or personal tools.

 

Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Advertisement

Sign In to gain access to subscriptions and/or personal tools.
Journal of Pharmacy Practice
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
0897190008330201v1
22/5/489    most recent
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Minton, J. A.
Right arrow Articles by Shah, S. A.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Topics in Internal Medicine

Psychosis From Anticholinergic Medications Administered at a Smoking Cessation Clinic

Jenna A. Minton, PharmD
Toyin S. Tofade, MS, PharmD, BCPS
Sidharth A. Shah, MD

From the Wake Area Health Education Center, Raleigh, North Carolina (JAM, TST); University of North Carolina, Eshelman School of Pharmacy, Chapel Hill, North Carolina, (TST); and Wake Forest University Health Sciences, Section on Cardiology, Winston Salem, North Carolina, (SAS). JAM was a student at Wake Area Health Education Center when this article was written.

Correspondence: Toyin S. Tofade, University of North Carolina, Eshelman School of Pharmacy, Chapel Hill, NC; e-mail: ttofade{at}wakemed.org.

Anticholinergic medications are used for a variety of reasons, from their effects on the central nervous system to their effects on the gastrointestinal tract. They are used in the treatment of Parkinson’s disease, vertigo, gastroesophageal reflux disease, and peptic ulcer disease. They have also been used in the treatment of motion sickness. These medications must be used with caution due to their effects on other systems, including the central nervous system. Common central nervous system side effects due to anticholinergic medications include sedation, delirium, amnesia, and in the case of the patient presented in this report, psychosis. A 61-year-old man presented to the emergency department with visual and auditory hallucinations secondary to anticholinergic medications (scopolamine and atropine) he received in a smoking cessation clinic. Previous cases of anticholinergic medication–induced psychosis are also summarized.

Key Words: smoking cessation • anticholinergics • toxicity • psychosis • hallucinations • delirium • scopolamine

This version was published on October 1, 2009

Journal of Pharmacy Practice, Vol. 22, No. 5, 489-493 (2009)
DOI: 10.1177/0897190008330201


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?




Advertisement